Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06754397

Diagnostic Accuracy of Magnetic Resonance Cholangiopancreatography in Patients With Obstructive Jaundice

Diagnostic Accuracy of Magnetic Resonance Cholangiopancreatography as Compared to Ultrasound and Computed Tomography in Patients With Obstructive Jaundice

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
Sohag University · Academic / Other
Sex
All
Age
15 Years – 89 Years
Healthy volunteers
Not accepted

Summary

Evaluate the diagnostic accuracy of Magnetic Resonance Cholangiopancreatography (MRCP) compared with Ultrasound and Computed Tomography (CT) in patients with obstructive jaundice taking findings of ERCP/ PTC and histopathology as gold standard.

Detailed description

MRCP as a diagnostic role to determine the presence and severity of biliary and pancreatic ductal dilatation. It can also detect the length of the stricture as well as the exact cause and location of the obstructing lesion in comparison to other modalities.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTMagnetic Resonance CholangiopancreatographyThree most important sequences included axial T2 weighted scan from liver to ampullary region followed by T2 weighted 3D FSE sequence acquired in coronal oblique plane using respiratory triggering by tying bellows over abdomen. After this breath hold HASTE sequence is acquired in coronal plane. Maximum intensity projection (MIP) and thick slab images are also used for interpretation. US, CECT and MRCP scans are interpreted by radiologists blinded to other imaging findings

Timeline

Start date
2025-01-01
Primary completion
2025-12-01
Completion
2025-12-01
First posted
2024-12-31
Last updated
2024-12-31

Source: ClinicalTrials.gov record NCT06754397. Inclusion in this directory is not an endorsement.